Events

Gene Therapy for Opthalmic Disease - the Genable Approach

On the afternoon of the 24th July 2012 at the Alexander Hotel, Merrion Square, Dublin, Genable will host a two hour presentation for interested parties on Gene Therapy for Ophthalmic Disease.

The program for the afternoon is as follows:

14.00 Welcome Address, Dr. Jason Loveridge CEO Genable Technologies

14.10 Gene therapy for retinal disease - the Genable approach, Prof. Jane Farrar CSO Genable Technologies

14.25 Gene therapy - a regulatory viewpoint, Prof. Alan Boyd Genable Technologies

14.40 Retinal pigmentosa - the patients perspective, Avril Daly CEO Fighting Blindness Ireland

14.50 Genable Technologies, a brief overview, Dr. Jason Loveridge

15.00 Q&A

15.15 Afternoon tea

16.00 Close

Should you be interested in attending could you please contact Genable staff at info@genable.ie before the 15th July 2012.

We look forward to meeting with you personally on the 24th.